China’s first approved vascular robot achieves 100% success rate in clinical trial
SMRTR summary
China's first approved vascular robot, the YDHB-NS01, achieved a 100% success rate in a clinical trial at Peking Union Medical College Hospital, where it performed complex brain imaging procedures called cerebral angiography. The robotic system reduced procedure time by 29% compared to manual methods, cutting average surgery duration from 38 to 27 minutes while protecting doctors from radiation exposure and physical strain. All 50 procedures were successfully completed with perfect diagnostic clarity, demonstrating the robot's potential to revolutionize neurosurgery.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article